Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies.
about
Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's diseaseProtein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseasesThe role of biomarkers in clinical trials for Alzheimer diseaseSporadic cerebral amyloid angiopathy--an important cause of cerebral haemorrhage in older people.Constraint-induced movement therapy as a paradigm of translational research in neurorehabilitation: Reviews and prospectsPost-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's diseasePreclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.Biomedical imaging research: a fast-emerging area for interdisciplinary collaboration.Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's diseaseQuick assembly of 1,4-diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease.Impact of amyloid imaging on drug development in Alzheimer's disease.Translational research in central nervous system drug discovery.A century-old debate on protein aggregation and neurodegeneration enters the clinic.Synthesis of Fluorescent Probes based on Stilbenes and Diphenylacetylenes targeting β-Amyloid Plaques.Strategies for molecular imaging dementia and neurodegenerative diseases.Small molecule inhibitors of Abeta assembly.Fluoro-pegylated (FPEG) imaging agents targeting Abeta aggregates.Synthesis of biphenyltrienes as probes for beta-amyloid plaques.Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.La lunga attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease.Challenges to demonstrating disease-modifying effects in Alzheimer's disease clinical trials.
P2860
Q24633911-0E46A847-18BC-45BC-8CA1-DDD7C6826640Q24650014-7844CA97-656F-4324-A501-437AE6F69DD5Q31032781-8E8DE0D3-BABE-4869-96A8-92190DDCA429Q31061495-6A932502-D286-470A-A09F-2F8E7EBF7568Q34310248-CBB16ED6-6E7F-4530-8767-4B343136D369Q34589414-EF9152B7-7F23-4899-9070-042B779A03E0Q34725521-331B3775-6AB2-4950-A843-068462B5523DQ35692002-A43570FA-C3C3-4525-9290-426D8CE895D3Q36026695-4871285B-585B-4DF9-8D25-4030798C96C0Q36028775-7AC9CB60-B7CC-4874-B21C-C3902A467DFEQ36144632-54BC7275-E83B-4258-A736-24E0DF463A57Q36401418-DCD4925F-7456-4901-8278-BA3D363DA595Q36628151-BCF15265-5251-42E3-A139-98ABDB6F8CCFQ36825129-CCCD3D53-3AAB-44C1-8BAD-560FF33CF0F5Q36853915-444B2D16-19DD-4BAC-A991-36C908874740Q36911406-83121085-8610-448E-B983-C06C93982ABCQ37002944-18B4FFE7-1155-4959-B055-120E366E0BF8Q37003006-FA66EB62-D9AD-4F57-B619-3D2F9B19020CQ47407570-F6548399-64DA-4A96-91FF-BCB10AD2259EQ48396205-6106FC6E-01C1-4846-8C39-5FCBA0FF7173Q55112408-A80E2080-EE66-4185-BB85-124B6EBEFD56
P2860
Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Imaging technology for neurode ...... ction of specific pathologies.
@ast
Imaging technology for neurode ...... ction of specific pathologies.
@en
type
label
Imaging technology for neurode ...... ction of specific pathologies.
@ast
Imaging technology for neurode ...... ction of specific pathologies.
@en
prefLabel
Imaging technology for neurode ...... ction of specific pathologies.
@ast
Imaging technology for neurode ...... ction of specific pathologies.
@en
P2093
P1433
P1476
Imaging technology for neurode ...... ction of specific pathologies.
@en
P2093
Chester A Mathis
Julie C Price
Steven T DeKosky
P304
P356
10.1001/ARCHNEUR.62.2.196
P577
2005-02-01T00:00:00Z